• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Portable Finger Probe Measures Liver Function in Potential Donors

  Pulsion device
 

The Pulsion device successfully measured liver function in potential donors
Image: Courtesy of Pulsion

A portable finger-probe device that has successfully measured liver function in brain-dead adult organ donors could change the way organs are assessed and save thousands of dollars per transplant, a UCLA study has found. Working with OneLegacy, the non-profit organ- and tissue-recovery organization serving the Greater Los Angeles area, UCLA researchers measured liver function in 53 potential organ donors in a blind study of the device. Eleven livers were declined because of poor quality; the function of the 42 that were transplanted was tested later to compare to the results obtained using the device.

“This Pulsion device is the best single predictor of organ survival in our patients,” says Ali Zarrinpar, MD (RES ’10, FEL ’12), PhD, assistant professor of surgery in the Division of Liver and Pancreas Transplantation. “It gives us a quantitative measure of how good a liver is without having to visually inspect the organ.”

Although there are accurate and reliable function tests for other donor organs, this is not the case for livers, Dr. Zarrinpar says. Currently, depending on a thorough assessment of a potential donor’s medical history, multiple blood tests and any hospital treatments, a surgical team from the recipient’s medical center is dispatched to the donor’s location to visually inspect and potentially procure the organ. That team costs thousands of dollars per procedure, Dr. Zarrinpar says, and about 10-to-15 percent of the time the organ is deemed unusable.

On the flip side, an organ from a patient with a questionable history or borderline laboratory results may be considered a waste of the surgical team’s time and the retrieval effort abandoned. However, this device could easily be used to test organ function in such marginal donors, so its use could increase the number of organs used for transplant.

The device operates much like a pulse oximeter; it measures the rate at which a dye injected into the potential donor’s bloodstream is cleared by the liver. This novel, noninvasive and rapid test successfully predicted which livers would function properly in transplant patients, Dr. Zarrinpar says. “These data warrant further exploration in a larger trial in a variety of settings to evaluate acceptable values for donated livers,” the study states. “At a time of increasing regional sharing and calls for national organ sharing, this method would assist in the standardization of graft evaluation. It could also lead to increasing liver graft utilization while decreasing travel risk and expenses.”

"A Rapid, Reproducible, Noninvasive Predictor of Liver Graft Survival,” Journal of Surgical Research, July 2015


Previous
Camp Leg Power Propels Kids with Cerebral Palsy Forward
Next
Stem-cell Therapy Holds Promise for Eliminating HIV Infection


YOU ARE VIEWING

Fall 2015

Fall 2015
E-Brochure
Printable PDF
IN THIS ISSUE
  • We Are the World
  • Camp Leg Power Propels Kids with Cerebral Palsy Forward
  • Portable Finger Probe Measures Liver Function in Potential Donors
  • Stem-cell Therapy Holds Promise for Eliminating HIV Infection
  • REM Sleep Helps Brain Capture Snapshots of Dream Images
  • Germline Cells Shown to be Vulnerable during Pregnancy
  • New Study Opens Window on Mutations in Genetic Architecture of Schizophrenics
  • How Molecular Rules Govern Autoimmune Disorders
  • Predicting Response to Treatment for Obsessive-Compulsive Disorder
  • Why Children’s Recovery Times Vary after Traumatic Brain Injury
  • Potentially Effective Treatment for Meth Addiction
  • Protein that Helps Suppress Cancer Fades as We Age
  • Patient First to Bridge from Experimental Total Artificial Heart to Transplant
  • UCLA Community Based Learning: Bridging the Transition from Youth to Adulthood
  • Get Social
  • The End of Darkness
  • Medicine 2.0
  • White Knight
  • Awards, Honors & Grants
  • In Memoriam
  • Postcard from Malawi
  • In Her Own Words: Lynn L. Huang, MD ’07
  • The Business of Medical Innovation
  • Tribute to a Mentor and Friend
  • Kaleidoscope Ball Highlights Artistic Variety
  • Landmark Gift Paves the Way for Breakthroughs
  • The UCLA Today’s and Tomorrow’s Children’s Fund Names New Awardees
  • Golden Portal Fundraiser Joins Movies, Medicine and Technology
  • Widening the Circle of Giving
  • UCLA Names Landmark New Medical-Education Building Geffen Hall
  • Gifts
  • In Memoriam
  • Good Afternoon, Mrs. Gates
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth